» Articles » PMID: 29742909

Olfactory Testing in Frontotemporal Dementia: A Literature Review

Overview
Publisher Sage Publications
Specialty Neurology
Date 2018 May 11
PMID 29742909
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Frontotemporal dementia (FTD) is a heterogeneous disorder featuring language impairment, personality changes, and executive defects, often due to the frontotemporal lobar degeneration (FTLD). Both FTD and FTLD are often associated with olfactory impairment, early biomarker for neurodegeneration, which can be evaluated with different techniques, among which low-cost olfactory tests are widely used. Therefore, we conducted a review of the literature focusing on papers published between January 1, 2007, and June 12, 2017, investigating the usefulness of olfactory testing in FTD/FTLD. A general decrease in the olfactory identification ability was seen in most of the articles and, taken together with a preserved odor discrimination, reveals a higher order impairment, possibly linked to cognitive decrease or language impairments, and not to a specific deficit of the olfactory system. This evidence could represent a useful add-on to the current literature, increasing the diagnostic value of olfactory assessment, particularly in cases where differential diagnosis is difficult.

Citing Articles

The New Zealand Genetic Frontotemporal Dementia Study (FTDGeNZ): a longitudinal study of pre-symptomatic biomarkers.

Ryan B, OMara Baker A, Ilse C, Brickell K, Kersten H, Williams J J R Soc N Z. 2024; 53(4):511-531.

PMID: 39439966 PMC: 11459842. DOI: 10.1080/03036758.2022.2101483.


Olfactory Function as a Potential Predictor of Cognitive Impairment in Men and Women.

Masala C, Loy F, Pinna I, Manis N, Ercoli T, Solla P Biology (Basel). 2024; 13(7).

PMID: 39056696 PMC: 11274230. DOI: 10.3390/biology13070503.


Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients.

Huang X, Wu J, Zhang N, Teng J, Yang Q, Zhang Y CNS Neurosci Ther. 2024; 30(7):e14851.

PMID: 38978196 PMC: 11230928. DOI: 10.1111/cns.14851.


Associations Between Cognitive Function, Depression, and Olfactory Function in Elderly People With Dementia in Korea.

Cha H, Kim S, Son Y Front Aging Neurosci. 2022; 13:799897.

PMID: 35087394 PMC: 8787281. DOI: 10.3389/fnagi.2021.799897.


Vitamin D and Folate as Predictors of MMSE in Alzheimer's Disease: A Machine Learning Analysis.

Murdaca G, Banchero S, Tonacci A, Nencioni A, Monacelli F, Gangemi S Diagnostics (Basel). 2021; 11(6).

PMID: 34073931 PMC: 8225187. DOI: 10.3390/diagnostics11060940.


References
1.
Doty R, Shaman P, DANN M . Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984; 32(3):489-502. DOI: 10.1016/0031-9384(84)90269-5. View

2.
Minami S, Min S, Krabbe G, Wang C, Zhou Y, Asgarov R . Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models. Nat Med. 2014; 20(10):1157-64. PMC: 4196723. DOI: 10.1038/nm.3672. View

3.
Orasji S, Mulder J, de Bruijn S, Wirtz P . Olfactory dysfunction in behavioral variant frontotemporal dementia. Clin Neurol Neurosurg. 2016; 141:106-10. DOI: 10.1016/j.clineuro.2016.01.003. View

4.
Petoukhov E, Fernando S, Mills F, Shivji F, Hunter D, Krieger C . Activity-dependent secretion of progranulin from synapses. J Cell Sci. 2013; 126(Pt 23):5412-21. DOI: 10.1242/jcs.132076. View

5.
Zelaya M, Perez-Valderrama E, Martinez de Morentin X, Tunon T, Ferrer I, Luquin M . Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies. Oncotarget. 2015; 6(37):39437-56. PMC: 4741837. DOI: 10.18632/oncotarget.6254. View